PIONEERING NEW POSSIBILITIES IN BIOELECTRONIC MEDICINE
SetPoint Medical is pioneering bioelectronic medicine to offer patients and providers a potentially safe and cost-effective approach for treatment of chronic autoimmune diseases.
The convergence of extraordinary advances in immunology, neuroscience and bioengineering have resulted in development of an entirely new treatment approach.Learn more about the science
SetPoint Medical’s platform uses pathways designed to deliver
targeted electrical pulses along existing
physiologic pathways to trigger the
body’s own biological responses.
SetPoint Medical is committed to evidence-based advancement of treatment options for chronic autoimmune diseases through robust clinical research.
SetPoint Medical has brought together a unique group of professionals with expertise across medical devices, pharmaceuticals and consumer technology fields to assemble a team dedicated to improving patient care.
February 1, 2021
SetPoint Medical Raises $64M in Preferred Stock Financing to Support Pivotal Trial for its Novel Bioelectro...Read Press Release from
January 27, 2021
October 6, 2020
INVESTIGATIONAL DEVICE DISCLAIMER: The SetPoint Medical device is an investigational device. It is currently undergoing clinical evaluation under Food and Drug Administration’s Investigational Device Exemption and is not approved for commercial use.